United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Pharma Industry News Breakthrough discovery at NYU Langone Medical Center offers new hope for Gaucher’s Disease treatment Researchers at NYU Langone Medical Center in New York City have made an unexpected breakthrough in the treatment… bypharmanewsdailyOctober 25, 2016